Immunocore's Tebentafusp Sole Winner In EU Fast-Track Stakes In June
European Medicines Agency's CHMP Rejected Four Out Of Five Requests
• By Maureen Kenny
The EMA will fast track its review of advanced uveal melanoma drug tebentafusp. • Source: Alamy 
